- call +1-201-465-4211
- email sales@mrinsights.biz
A microRNA (abbreviated miRNA) is a small non-coding RNA molecule (containing about 22 nucleotides) found in plants, animals and some viruses, that functions in RNA silencing and post-transcriptional regulation of gene expression.
Scope of the Report:
This report studies the MicroRNA market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the MicroRNA market by product type and applications/end industries.
PCR based arrays dominated the global microRNA market in revenue terms in 2017, and the trend is projected to continue throughout the forecast period.
The global MicroRNA market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of MicroRNA.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Illumina
Roche
Agilent
Bio-Rad
Sigma Aldrich
Qiagen
Thermo Fisher Scientific
HTG Molecular Diagnostics
Meridian Life Science
Rosetta Genomics
Dharmacon
BioVendor
Miltenyi Biotec
Kaneka Corporation
Abcam
GeneCopoeia
Promega Corporation
New England Biolabs
NanoString Technologies
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
PCR-based Assay
miRNA Arrays
Next Generation Sequencing (NGS)
Immunoassay
Market Segment by Applications, can be divided into
Diagnostic Centers
Academic and Research Institutes
Biopharmaceutical Companies
Contract Research Organizations
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 MicroRNA Market Overview
1.1 Product Overview and Scope of MicroRNA
1.2 Classification of MicroRNA by Types
1.2.1 Global MicroRNA Revenue Comparison by Types (2017-2023)
1.2.2 Global MicroRNA Revenue Market Share by Types in 2017
1.2.3 PCR-based Assay
1.2.4 miRNA Arrays
1.2.5 Next Generation Sequencing (NGS)
1.2.6 Immunoassay
1.3 Global MicroRNA Market by Application
1.3.1 Global MicroRNA Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Diagnostic Centers
1.3.3 Academic and Research Institutes
1.3.4 Biopharmaceutical Companies
1.3.5 Contract Research Organizations
1.4 Global MicroRNA Market by Regions
1.4.1 Global MicroRNA Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) MicroRNA Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) MicroRNA Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) MicroRNA Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) MicroRNA Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) MicroRNA Status and Prospect (2013-2023)
1.5 Global Market Size of MicroRNA (2013-2023)
2 Manufacturers Profiles
2.1 Illumina
2.1.1 Business Overview
2.1.2 MicroRNA Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Illumina MicroRNA Revenue, Gross Margin and Market Share (2016-2017)
2.2 Roche
2.2.1 Business Overview
2.2.2 MicroRNA Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Roche MicroRNA Revenue, Gross Margin and Market Share (2016-2017)
2.3 Agilent
2.3.1 Business Overview
2.3.2 MicroRNA Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Agilent MicroRNA Revenue, Gross Margin and Market Share (2016-2017)
2.4 Bio-Rad
2.4.1 Business Overview
2.4.2 MicroRNA Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Bio-Rad MicroRNA Revenue, Gross Margin and Market Share (2016-2017)
2.5 Sigma Aldrich
2.5.1 Business Overview
2.5.2 MicroRNA Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Sigma Aldrich MicroRNA Revenue, Gross Margin and Market Share (2016-2017)
2.6 Qiagen
2.6.1 Business Overview
2.6.2 MicroRNA Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Qiagen MicroRNA Revenue, Gross Margin and Market Share (2016-2017)
2.7 Thermo Fisher Scientific
2.7.1 Business Overview
2.7.2 MicroRNA Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Thermo Fisher Scientific MicroRNA Revenue, Gross Margin and Market Share (2016-2017)
2.8 HTG Molecular Diagnostics
2.8.1 Business Overview
2.8.2 MicroRNA Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 HTG Molecular Diagnostics MicroRNA Revenue, Gross Margin and Market Share (2016-2017)
2.9 Meridian Life Science
2.9.1 Business Overview
2.9.2 MicroRNA Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Meridian Life Science MicroRNA Revenue, Gross Margin and Market Share (2016-2017)
2.10 Rosetta Genomics
2.10.1 Business Overview
2.10.2 MicroRNA Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Rosetta Genomics MicroRNA Revenue, Gross Margin and Market Share (2016-2017)
2.11 Dharmacon
2.11.1 Business Overview
2.11.2 MicroRNA Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Dharmacon MicroRNA Revenue, Gross Margin and Market Share (2016-2017)
2.12 BioVendor
2.12.1 Business Overview
2.12.2 MicroRNA Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 BioVendor MicroRNA Revenue, Gross Margin and Market Share (2016-2017)
2.13 Miltenyi Biotec
2.13.1 Business Overview
2.13.2 MicroRNA Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Miltenyi Biotec MicroRNA Revenue, Gross Margin and Market Share (2016-2017)
2.14 Kaneka Corporation
2.14.1 Business Overview
2.14.2 MicroRNA Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Kaneka Corporation MicroRNA Revenue, Gross Margin and Market Share (2016-2017)
2.15 Abcam
2.15.1 Business Overview
2.15.2 MicroRNA Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Abcam MicroRNA Revenue, Gross Margin and Market Share (2016-2017)
2.16 GeneCopoeia
2.16.1 Business Overview
2.16.2 MicroRNA Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 GeneCopoeia MicroRNA Revenue, Gross Margin and Market Share (2016-2017)
2.17 Promega Corporation
2.17.1 Business Overview
2.17.2 MicroRNA Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Promega Corporation MicroRNA Revenue, Gross Margin and Market Share (2016-2017)
2.18 New England Biolabs
2.18.1 Business Overview
2.18.2 MicroRNA Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 New England Biolabs MicroRNA Revenue, Gross Margin and Market Share (2016-2017)
2.19 NanoString Technologies
2.19.1 Business Overview
2.19.2 MicroRNA Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 NanoString Technologies MicroRNA Revenue, Gross Margin and Market Share (2016-2017)
3 Global MicroRNA Market Competition, by Players
3.1 Global MicroRNA Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 MicroRNA Players Market Share
3.2.2 Top 10 MicroRNA Players Market Share
3.3 Market Competition Trend
4 Global MicroRNA Market Size by Regions
4.1 Global MicroRNA Revenue and Market Share by Regions
4.2 North America MicroRNA Revenue and Growth Rate (2013-2018)
4.3 Europe MicroRNA Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific MicroRNA Revenue and Growth Rate (2013-2018)
4.5 South America MicroRNA Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa MicroRNA Revenue and Growth Rate (2013-2018)
5 North America MicroRNA Revenue by Countries
5.1 North America MicroRNA Revenue by Countries (2013-2018)
5.2 USA MicroRNA Revenue and Growth Rate (2013-2018)
5.3 Canada MicroRNA Revenue and Growth Rate (2013-2018)
5.4 Mexico MicroRNA Revenue and Growth Rate (2013-2018)
6 Europe MicroRNA Revenue by Countries
6.1 Europe MicroRNA Revenue by Countries (2013-2018)
6.2 Germany MicroRNA Revenue and Growth Rate (2013-2018)
6.3 UK MicroRNA Revenue and Growth Rate (2013-2018)
6.4 France MicroRNA Revenue and Growth Rate (2013-2018)
6.5 Russia MicroRNA Revenue and Growth Rate (2013-2018)
6.6 Italy MicroRNA Revenue and Growth Rate (2013-2018)
7 Asia-Pacific MicroRNA Revenue by Countries
7.1 Asia-Pacific MicroRNA Revenue by Countries (2013-2018)
7.2 China MicroRNA Revenue and Growth Rate (2013-2018)
7.3 Japan MicroRNA Revenue and Growth Rate (2013-2018)
7.4 Korea MicroRNA Revenue and Growth Rate (2013-2018)
7.5 India MicroRNA Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia MicroRNA Revenue and Growth Rate (2013-2018)
8 South America MicroRNA Revenue by Countries
8.1 South America MicroRNA Revenue by Countries (2013-2018)
8.2 Brazil MicroRNA Revenue and Growth Rate (2013-2018)
8.3 Argentina MicroRNA Revenue and Growth Rate (2013-2018)
8.4 Colombia MicroRNA Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue MicroRNA by Countries
9.1 Middle East and Africa MicroRNA Revenue by Countries (2013-2018)
9.2 Saudi Arabia MicroRNA Revenue and Growth Rate (2013-2018)
9.3 UAE MicroRNA Revenue and Growth Rate (2013-2018)
9.4 Egypt MicroRNA Revenue and Growth Rate (2013-2018)
9.5 Nigeria MicroRNA Revenue and Growth Rate (2013-2018)
9.6 South Africa MicroRNA Revenue and Growth Rate (2013-2018)
10 Global MicroRNA Market Segment by Type
10.1 Global MicroRNA Revenue and Market Share by Type (2013-2018)
10.2 Global MicroRNA Market Forecast by Type (2018-2023)
10.3 PCR-based Assay Revenue Growth Rate (2013-2023)
10.4 miRNA Arrays Revenue Growth Rate (2013-2023)
10.5 Next Generation Sequencing (NGS) Revenue Growth Rate (2013-2023)
10.6 Immunoassay Revenue Growth Rate (2013-2023)
11 Global MicroRNA Market Segment by Application
11.1 Global MicroRNA Revenue Market Share by Application (2013-2018)
11.2 MicroRNA Market Forecast by Application (2018-2023)
11.3 Diagnostic Centers Revenue Growth (2013-2018)
11.4 Academic and Research Institutes Revenue Growth (2013-2018)
11.5 Biopharmaceutical Companies Revenue Growth (2013-2018)
11.6 Contract Research Organizations Revenue Growth (2013-2018)
12 Global MicroRNA Market Size Forecast (2018-2023)
12.1 Global MicroRNA Market Size Forecast (2018-2023)
12.2 Global MicroRNA Market Forecast by Regions (2018-2023)
12.3 North America MicroRNA Revenue Market Forecast (2018-2023)
12.4 Europe MicroRNA Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific MicroRNA Revenue Market Forecast (2018-2023)
12.6 South America MicroRNA Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa MicroRNA Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure MicroRNA Picture
Table Product Specifications of MicroRNA
Table Global MicroRNA and Revenue (Million USD) Market Split by Product Type
Figure Global Mic
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
